JTCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Richard Lee
Marc R. Moon
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, R.
Right arrow Articles by Moon, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, R.
Right arrow Articles by Moon, M. R.
Related Collections
Right arrow Valve disease

J Thorac Cardiovasc Surg 2003;125:725-727
© 2003 The American Association for Thoracic Surgery

Brief Communications

Homograft valve repair for recurrent prosthetic valve endocarditis

Richard Lee, MD, Marc R. Moon, MD St Louis, Mo

From the Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Mo.

Received for publication May 16, 2002. Accepted for publication June 13, 2002. Address for reprints: Marc R. Moon, MD, Division of Cardiothoracic Surgery, Washington University School of Medicine, 3108 Queeny Tower, No. 1 Barnes-Jewish Plaza, St Louis, MO 63110 (E-mail: moonm@msnotes.wustl.edu).

The first 20% of the full text of this article appears below.

Surgical management of prosthetic valve endocarditis (PVE) remains a formidable challenge, especially for patients who continue intravenous drug use after successful initial treatment.Go Go 1,2 In an effort to reduce the rate of recurrent endocarditis, strategies including aortic valve repair and aortic root replacement with a homograft have been reported.Go Go 1,3 However, recurrent endocarditis of an aortic homograft represents a clinical problem without a well-established solution. This report details the treatment of a second recurrence of PVE in an intravenous drug user who had undergone homograft root replacement 11 months previously for endocarditis of an aortic valve bioprosthesis.

Clinical summary

A 43-year-old woman with diabetes mellitus and a 25-year history of intravenous drug use was seen in June 2000 with a history of fever, chills, and a cough for several weeks. Blood cultures revealed Streptococcus sanguis. Transthoracic echocardiography revealed severe aortic insufficiency and a large vegetation on the noncoronary cusp of the valve. The development of severe congestive heart failure necessitated aortic valve replacement. At . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The American Association for Thoracic Surgery.